/https%3A%2F%2Fwww.omnycontent.com%2Fd%2Fplaylist%2F60b2e926-e5f8-4b90-a465-aef901163001%2F95fd7c59-790d-496e-bbde-aef901167fe4%2F8ae54763-9925-40ca-8c3d-aef901167ffb%2Fimage.jpg%3Ft%3D1661187242%26size%3DLarge)
The Morning Brief
The Economic Times
Liquid Biopsy: Catching Cancer Early With a Simple Blood Test
NOV 12, 202627 MIN
/https%3A%2F%2Fwww.omnycontent.com%2Fd%2Fclips%2F60b2e926-e5f8-4b90-a465-aef901163001%2F95fd7c59-790d-496e-bbde-aef901167fe4%2Fd3302ac2-9039-42c2-b6a6-b4ff00f047e1%2Fimage.jpg%3Ft%3D1794408088%26size%3DLarge)
Description
In 2010, scientists Catherine Alix-Panabières and Klaus Pantel coined the term “liquid biopsy”, which Nature later named one of the key cancer discoveries of the last 20 years. Their blood-based approach can detect cancer early, spare patients painful needle biopsies, help doctors choose the right therapy and flag when a treatment stops working. Professor Pantel says a $1,000 test could save around $10,000 in ineffective treatment. In this conversation with The Economic Times pharma editor Vikas Dandekar, they explain why adoption is still slow, how India can take a bigger role in global clinical trials, and how immunotherapy and AI could shape the future of cancer care. Listen in
See omnystudio.com/listener for privacy information.

